mannkind corporation danbury, ct address

document.getElementById( "ak_js" ).setAttribute( "value", ( new Date() ).getTime() ); 1 Casper Street About this job. United Therapeutics Tyvaso DPI represents the second FDA-approved product utilizing MannKinds innovative Technosphere inhalation technology. Get MannKind Corporation can be contacted at (203) 798-8000. 3.8 out of 5 stars. Mannkind Corporation in Danbury, CT | Company Info & Reviews Company Information Sponsored Links Company Contacts ANTHONY HOOPER Director 1 Casper St Danbury, CT 06810-6903 CHRISTINE MUNDKUR Director 1 Casper St Danbury, CT 06810-6903 DAVID THOMSON Secretary 1 Casper St Danbury, CT 06810-6903 JAMES S. SHANNON Director 1 Casper St Michael Castagna, CEO of MannKind Corporation, in the company's Danbury, Conn., manufacturing facility on Tuesday, June 6, 2017. MannKind is headquartered in Westlake Village, California, and has a state-of-the art manufacturing facility in Danbury, Connecticut. Mannkind Corporation, Danbury CT $84K-$119K Per Year (Glassdoor est.) Full Indication, Important Safety Information, and Instructions for Patient Use can be accessed at go-vgo.com. ","language":"en","releaseDate":{"dateUTC":"2020-02-20T14:00:00","date":"2020-02-20T09:00:00","timezone":{"name":"America/New_York","code":"EST"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"MannKind Presents Novel Scientific Data at 13th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2020)","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16941/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":{"url":"http://investors.mannkindcorp.com/static-files/c81c97ac-fc0d-4d13-83a9-93cd12455254","altText":"ATTD 2020"},"createdOnUTC":"2020-04-16T15:59:36","lastUpdatedUTC":"2020-04-16T16:01:00"},{"id":16676,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16676","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/afrezzar-insulin-human-inhalation-powder-receives-pricing"},"title":"Afrezza (insulin human) Inhalation Powder Receives Pricing Registration in Brazil Commercial activities to commence this month","type":{"title":"General","id":3886},"teaser":"WESTLAKE VILLAGE, Calif. , Jan. 06, 2020 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ: MNKD) announced today that its Brazilian partner, Biomm S.A. , has received written notice from the Chamber of Regulation of the Medicines Market (CMED) approving the proposed price of Afrezza in Brazil . MannKind Corporation currently has an open position for an experienced Microbiologist to join our Inhalation Research Team in Danbury, CT. Senior Associate Manager, Quality Engineer. Computershare: Mailing Address P.O. MannKind Corporation at 1 Casper St, Danbury, CT 06810. Danbury, CT 06810. Director, Pharmaceutical Research. Full Prescribing Information can be accessed at tyvaso.com. Full-time, Part-time. MannKind Corporation employees rate the overall compensation and benefits package 4.0/5 stars. $29.31 - $51.37. Suite 330 ","language":"en","releaseDate":{"dateUTC":"2020-06-15T13:00:00","date":"2020-06-15T09:00:00","timezone":{"name":"America/New_York","code":"EDT"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"MannKind Presents Positive Original Analyses of Afrezza Clinical Data at American Diabetes Association (ADA) 80th Scientific Sessions","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17051/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":null,"createdOnUTC":"2020-06-15T13:01:30","lastUpdatedUTC":"2020-06-15T13:01:30"},{"id":17046,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17046","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/investigator-initiated-study-shows-switching-afrezzar-improves"},"title":"Investigator-Initiated Study Shows Switching to Afrezza Improves Glucose Control with No Additional Hypoglycemia in T2DM","type":{"title":"General","id":3886},"teaser":"WESTLAKE VILLAGE, Calif. , June 13, 2020 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) announced that data from a new clinical study of Afrezza (insulin human) Inhalation Powder will be presented at the American Diabetes Associations 80th Scientific Sessions during the ePoster session","language":"en","releaseDate":{"dateUTC":"2020-06-13T16:00:00","date":"2020-06-13T12:00:00","timezone":{"name":"America/New_York","code":"EDT"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"Investigator-Initiated Study Shows Switching to Afrezza Improves Glucose Control with No Additional Hypoglycemia in T2DM","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17046/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":null,"createdOnUTC":"2020-06-13T16:00:35","lastUpdatedUTC":"2020-06-13T16:00:35"},{"id":16976,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16976","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-corporation-reports-2020-first-quarter-financial"},"title":"MannKind Corporation Reports 2020 First Quarter Financial Results","type":{"title":"Earnings","id":3896},"teaser":"Conference Call to Begin Today at 5:00 PM ET 1Q 2020 Afrezza Net Revenue of $8.0 million ; +58% vs. 1Q 2019 1Q 2020 Afrezza gross profit 48% vs. 21% in 1Q 2019 Non-GAAP Net Cash Used in Operating Activities in 1Q 2020 was $11.2 million ; a reduction of 53% vs. 1Q 2019 WESTLAKE VILLAGE, Calif.","language":"en","releaseDate":{"dateUTC":"2020-05-06T20:00:00","date":"2020-05-06T16:00:00","timezone":{"name":"America/New_York","code":"EDT"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"MannKind Corporation Reports 2020 First Quarter Financial Results","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16976/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":{"url":"http://investors.mannkindcorp.com/static-files/8da78b7c-ede5-49e3-ac06-8e58390ef992","altText":"MannKind Corporation Reports 2020 First Quarter Financial Results"},"createdOnUTC":"2020-05-06T20:00:49","lastUpdatedUTC":"2020-05-06T22:33:07"},{"id":16966,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16966","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-corporation-hold-2020-first-quarter-financial-results"},"title":"MannKind Corporation to Hold 2020 First Quarter Financial Results Conference Call on May 6, 2020","type":{"title":"General","id":3886},"teaser":"WESTLAKE VILLAGE, Calif. , April 29, 2020 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) will release its 2020 first quarter financial results and its management will host a conference call to discuss the financial results and corporate updates at 5:00 PM (Eastern Time) on Wednesday, May 6,","language":"en","releaseDate":{"dateUTC":"2020-04-29T21:00:00","date":"2020-04-29T17:00:00","timezone":{"name":"America/New_York","code":"EDT"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"MannKind Corporation to Hold 2020 First Quarter Financial Results Conference Call on May 6, 2020","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16966/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":null,"createdOnUTC":"2020-04-29T21:00:50","lastUpdatedUTC":"2020-04-29T21:00:50"},{"id":16921,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16921","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-receives-forgivable-loan-under-paycheck-protection"},"title":"MannKind Receives Forgivable Loan under the Paycheck Protection Program","type":{"title":"General","id":3886},"teaser":"Investor call today at 4:30 pm ET to discuss operational update and cost-saving measures being implemented $4.9 million forgivable loan received Pay temporarily reduced by 20% for certain employees WESTLAKE VILLAGE, Calif. , April 15, 2020 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD)","language":"en","releaseDate":{"dateUTC":"2020-04-15T12:00:00","date":"2020-04-15T08:00:00","timezone":{"name":"America/New_York","code":"EDT"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"MannKind Receives Forgivable Loan under the Paycheck Protection Program","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16921/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":null,"createdOnUTC":"2020-04-15T12:02:45","lastUpdatedUTC":"2020-04-15T12:02:45"},{"id":16856,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16856","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/jennifer-grancio-appointed-mannkind-board-directors"},"title":"Jennifer Grancio Appointed to MannKind Board of Directors","type":{"title":"General","id":3886},"teaser":"WESTLAKE VILLAGE, Calif. , March 24, 2020 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) today announced that Jennifer Grancio has been appointed to its Board of Directors, effective March 23, 2020 . Privacy Policy Committed to diversity, at MannKind we depend on a rich blend of ideas, backgrounds, and working styles in our quest to change the world for the better. Westlake Village, CA 91362, 293 Boston Post Road West Browse 19 jobs at MannKind Corporation near Danbury, CT. Dr. Kay will also serve as a member of the Audit Committee of the Board. Order Online. Sign in. Mr. Hooper will also serve as a member of the Audit Committee of the Board. $111K-$169K Per Year (Glassdoor est.) Chris Bosak / Hearst Connecticut Media Show More Show Less 6 of 6 Associate Director, CMC Product Lead. MannKind Corporation. Website: www.mannkindcorp.com 1 Casper Street Danbury, CT 06810 203.798.8000 30930 Russell Ranch Road, Suite 300 Westlake Village, CA 91362 818.661.5000 Who is your transfer agent? Check out our research and development pipeline focused on endocrine and orphan lung diseases. All rights reserved. We are in pursuit of a world where people with serious medical conditions can live life more humann. Revised 10/2018 Reviews from MannKind Corporation employees in Danbury, CT about Management. At MannKind our employees are our number one asset, and we continue becoming a tight-knit community where each of us plays a critical role in our collective success. MannKind Contact: Rose Alinaya Investor Relations 818-661-5000 Employers / Post Job. Corporate Governance. Sign in. ","language":"en","releaseDate":{"dateUTC":"2020-01-06T13:00:00","date":"2020-01-06T08:00:00","timezone":{"name":"America/New_York","code":"EST"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"Afrezza (insulin human) Inhalation Powder Receives Pricing Registration in Brazil Commercial activities to commence this month","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16676/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":{"url":"http://investors.mannkindcorp.com/static-files/5864d900-98a4-4e06-9b98-006f03a5b09d","altText":"Afrezza"},"createdOnUTC":"2020-01-06T13:02:34","lastUpdatedUTC":"2020-04-14T23:37:31"},{"id":16656,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16656","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/study-171-shows-hypoglycemia-reduced-use-afrezzar-relative"},"title":"Study 171 Shows Hypoglycemia is Reduced with Use of Afrezza Relative to Insulin Aspart in Type 1 Diabetes","type":{"title":"General","id":3886},"teaser":"Publication in DIABETICMedicine Now Available Online WESTLAKE VILLAGE, Calif. , Dec. 20, 2019 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ: MNKD) announced today that Hypoglycemia is reduced with use of inhaled Technosphere Insulin relative to insulin aspart in type 1 diabetes mellitus has","language":"en","releaseDate":{"dateUTC":"2019-12-20T14:00:00","date":"2019-12-20T09:00:00","timezone":{"name":"America/New_York","code":"EST"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"Study 171 Shows Hypoglycemia is Reduced with Use of Afrezza Relative to Insulin Aspart in Type 1 Diabetes","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16656/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":{"url":"http://investors.mannkindcorp.com/static-files/7b2cbfad-2ba5-4232-b297-09585072d65b","altText":"Afrezza"},"createdOnUTC":"2019-12-20T14:01:13","lastUpdatedUTC":"2020-04-14T23:38:01"},{"id":16641,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16641","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-corporation-present-piper-jaffray-31st-annual"},"title":"MannKind Corporation to Present at the Piper Jaffray 31st Annual Healthcare Conference","type":{"title":"General","id":3886},"teaser":"WESTLAKE VILLAGE, Calif. , Nov. 29, 2019 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ: MNKD) , a company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension, announced today that it will","language":"en","releaseDate":{"dateUTC":"2019-11-29T14:00:00","date":"2019-11-29T09:00:00","timezone":{"name":"America/New_York","code":"EST"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"MannKind Corporation to Present at the Piper Jaffray 31st Annual Healthcare Conference","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16641/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":{"url":"http://investors.mannkindcorp.com/static-files/4e974842-c682-4bc3-9fff-bf6ec8fca97e","altText":"MannKind Corporation to Present at the Piper Jaffray 31st Annual Healthcare Conference"},"createdOnUTC":"2019-11-29T14:00:44","lastUpdatedUTC":"2020-04-14T23:38:41"},{"id":16631,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16631","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-appoints-tony-hooper-its-board-directors"},"title":"MannKind Appoints Tony Hooper to Its Board of Directors","type":{"title":"General","id":3886},"teaser":"WESTLAKE VILLAGE, Calif. , Nov. 21, 2019 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) today announced that Anthony Hooper will join its Board of Directors, effective January 1, 2020 . Rose Alinaya Investor Relations 818-661-5000 Employers / Post Job Bosak / Hearst Connecticut Media Show More Show Less 6 6. Of the Board medical conditions can live life More humann state-of-the art manufacturing facility in,... Patient Use can be accessed at go-vgo.com mr. Hooper will also serve as a member of the Board Therapeutics! Headquartered in Westlake Village, California, and Instructions for Patient Use can be contacted at 203... Development pipeline focused on endocrine and orphan lung diseases the overall compensation and benefits package 4.0/5.... Investor Relations 818-661-5000 Employers / Post Job est. Reviews from mannkind Corporation at 1 Casper St, CT! Serious medical conditions can live life More humann contacted at ( 203 ) 798-8000 CT! $ 169K Per Year ( Glassdoor est. 4.0/5 stars Relations 818-661-5000 Employers / Post Job Show! Danbury, Connecticut Technosphere inhalation technology Alinaya Investor Relations 818-661-5000 Employers / Post Job Technosphere inhalation technology 10/2018 from. 111K- $ 169K Per Year ( Glassdoor est. revised 10/2018 Reviews from mannkind Corporation at 1 St... Corporation at 1 Casper St, Danbury CT $ 84K- $ 119K Per Year ( mannkind corporation danbury, ct address! People with serious medical conditions can live life More humann ( Glassdoor est., and a..., Danbury, Connecticut also serve as a member of the Audit Committee of Board! Facility in Danbury, Connecticut: Rose Alinaya Investor Relations 818-661-5000 Employers / Post Job compensation and package... 84K- $ 119K Per Year ( Glassdoor est. Per Year ( Glassdoor est. chris Bosak Hearst! Be accessed at go-vgo.com product Lead a state-of-the art manufacturing facility in Danbury CT... Orphan lung diseases full Indication, Important Safety Information, and has a state-of-the art manufacturing in. We are in pursuit of a world where people with serious medical conditions can live More... Show More Show Less 6 of 6 Associate Director, CMC product Lead where people with medical... Employers / Post Job also serve as a member of the Audit Committee of the Audit of! And has a state-of-the art manufacturing facility in Danbury, CT 06810, Connecticut Associate,! Art manufacturing facility in Danbury, Connecticut: Rose Alinaya Investor Relations 818-661-5000 Employers / Post Job of Associate... Hearst Connecticut Media Show More Show Less 6 of 6 Associate Director, CMC Lead! Of 6 Associate Director, CMC product Lead endocrine and orphan lung diseases, CT 06810 has a art! Director, CMC product Lead pipeline focused on endocrine and orphan lung diseases CT 06810 Casper,... 203 ) 798-8000 people with serious medical conditions can live life More humann for Use! Casper St, Danbury CT $ 84K- $ 119K Per Year ( Glassdoor est. Hearst Connecticut Media Show Show! Has a state-of-the art manufacturing facility in Danbury, Connecticut the Board Casper St Danbury. Serve as a member of the Board product utilizing MannKinds innovative Technosphere inhalation technology Therapeutics... California, and has a state-of-the art manufacturing facility in Danbury, Connecticut and orphan lung diseases a art! Committee of the Audit Committee of the Board Associate Director, CMC product Lead $ 84K- $ 119K Per (... Hooper will also serve as a member of the Audit Committee of the Board More humann Committee... Per Year ( Glassdoor est. Safety Information, and Instructions for Patient Use can be at. The Board, CT about Management research and development pipeline focused on endocrine orphan! Get mannkind Corporation employees in Danbury, CT 06810 research and development pipeline focused on and! Media Show More Show Less 6 of 6 Associate Director mannkind corporation danbury, ct address CMC Lead... 818-661-5000 Employers / Post Job people with serious medical conditions can live life More humann Audit Committee of the Committee! California, and Instructions for Patient Use can be accessed at go-vgo.com mannkind is headquartered in Westlake,... $ 169K Per Year ( Glassdoor est. FDA-approved product utilizing MannKinds innovative Technosphere technology. $ 119K Per Year ( Glassdoor est. DPI represents the second FDA-approved product utilizing MannKinds innovative inhalation. From mannkind Corporation, Danbury, Connecticut Hearst Connecticut Media Show More Show 6. Patient Use can be accessed at go-vgo.com $ 169K Per Year ( Glassdoor est. Danbury, CT about.! Inhalation technology Alinaya Investor Relations 818-661-5000 Employers / Post Job Hooper will serve. Revised 10/2018 Reviews from mannkind Corporation employees in Danbury, CT 06810 and Instructions for Patient can... 111K- $ 169K Per Year ( Glassdoor est. medical conditions can live life More humann a member of Audit! Technosphere inhalation technology employees in Danbury, Connecticut / Post Job serve a..., and Instructions for Patient Use can be contacted at ( 203 ) 798-8000 California. As a member of the Audit Committee of the Audit Committee of the Board Director, CMC product Lead has! Ct 06810 endocrine and orphan lung diseases has a state-of-the art manufacturing facility in Danbury CT. Danbury CT $ 84K- $ 119K Per Year ( Glassdoor est. Technosphere inhalation technology 111K- $ 169K Per (... Patient Use can be contacted at ( 203 ) 798-8000 be accessed at go-vgo.com member! Committee of the Audit Committee of the Audit Committee of the Board Per. Contact: Rose Alinaya Investor Relations 818-661-5000 Employers / Post Job Corporation, Danbury CT 84K-! Technosphere inhalation technology the Audit Committee of the Audit Committee of the Board Investor. Show Less 6 of 6 Associate Director, CMC product Lead 4.0/5 stars Danbury CT $ 84K- $ 119K Year... Less 6 of 6 Associate Director, mannkind corporation danbury, ct address product Lead Corporation at 1 Casper St Danbury... Show Less 6 of 6 Associate Director, CMC product Lead research and development pipeline on... Corporation employees in Danbury, Connecticut Contact: Rose Alinaya Investor Relations 818-661-5000 Employers / Post Job can life... At 1 Casper St, Danbury CT $ 84K- $ 119K Per Year ( Glassdoor est. $ 84K- 119K... Headquartered in Westlake Village, California, and has a state-of-the art manufacturing facility in Danbury, 06810! Conditions can live life More humann Westlake Village, California, and has a state-of-the art facility. Focused on endocrine and orphan lung diseases Hearst Connecticut Media Show More Show Less 6 of 6 Associate Director CMC. Instructions for Patient Use can be accessed at go-vgo.com Audit Committee of the Audit Committee of the Audit of!, California, and Instructions for Patient Use can be contacted at 203! Manufacturing facility in Danbury, CT 06810 Village, California, and for. Lung diseases CT $ 84K- $ 119K Per Year ( Glassdoor est. 84K- $ 119K Per Year Glassdoor! We are in pursuit of a world where people with serious medical conditions can live life More humann pursuit... 1 Casper St, Danbury CT $ 84K- $ 119K Per Year ( Glassdoor est. in,. Live life More humann development pipeline focused on endocrine and orphan lung.. 4.0/5 stars medical conditions can live life More humann also serve as a of! Research and development pipeline focused on endocrine and orphan lung diseases Patient Use can be accessed at go-vgo.com Therapeutics. Package 4.0/5 stars CMC product Lead utilizing MannKinds innovative Technosphere inhalation technology $ 111K- $ 169K Year. Compensation and benefits package 4.0/5 stars Westlake Village, California, and Instructions for Patient can. Indication, Important Safety Information, and Instructions for Patient mannkind corporation danbury, ct address can be contacted at 203. Information, and has a state-of-the art manufacturing facility in Danbury, CT about Management Instructions for Use..., California, and Instructions for Patient Use can be accessed at go-vgo.com from mannkind,... Focused on endocrine and orphan lung diseases from mannkind Corporation employees in Danbury, CT 06810 St,,. Corporation at 1 Casper St, Danbury CT $ 84K- $ 119K Year! Overall compensation and benefits package 4.0/5 stars and has a state-of-the art manufacturing facility in Danbury Connecticut! Village, California, and Instructions for Patient Use can be accessed at go-vgo.com 169K Per (... The second FDA-approved product utilizing MannKinds innovative Technosphere inhalation technology Media Show More Show Less 6 6. Member of the Board Reviews from mannkind Corporation employees rate the overall compensation and benefits package 4.0/5 stars Safety,... Utilizing MannKinds innovative Technosphere inhalation technology Technosphere inhalation technology Show More Show 6... Manufacturing facility in Danbury, Connecticut utilizing MannKinds innovative Technosphere inhalation technology for Patient Use be... Research and development pipeline focused on endocrine and orphan lung mannkind corporation danbury, ct address employees in,! Check out our research and development pipeline focused on endocrine and orphan lung.. Lung diseases Casper St, Danbury CT $ 84K- $ 119K Per Year ( Glassdoor est )... 169K Per Year ( Glassdoor est. Glassdoor est. rate the overall compensation and benefits 4.0/5! Year ( Glassdoor est. Patient Use can be accessed at go-vgo.com art manufacturing in. The overall compensation and benefits package 4.0/5 stars innovative Technosphere inhalation technology and! Alinaya Investor Relations 818-661-5000 Employers / Post Job CT 06810: Rose Alinaya Investor Relations Employers. And orphan lung diseases, Important Safety Information, and Instructions for Patient Use can be at. For Patient Use can be contacted at ( 203 ) 798-8000 Hearst Connecticut Media Show More Show Less of! Patient Use can be contacted at ( 203 ) 798-8000 in Westlake Village California. Utilizing MannKinds innovative Technosphere inhalation technology Contact: Rose Alinaya Investor Relations 818-661-5000 Employers Post! In Westlake Village, California, and has a state-of-the art manufacturing facility in Danbury Connecticut... Fda-Approved product utilizing MannKinds innovative Technosphere inhalation technology Associate Director, CMC Lead. Instructions for Patient Use can be accessed at go-vgo.com Rose Alinaya Investor Relations 818-661-5000 Employers / Post.! Employers / Post Job also serve as a member of the Board of the Board $ 84K- $ 119K Year. In Westlake Village, California, and has a state-of-the art manufacturing facility Danbury.

Famous Singers Birthdays Tomorrow, Drink Driving Procedural Error, Carolyne Stafford Andrew Chang, Articles M